Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

FLCN helps control iron levels in cells.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Ciclosporin A effectively treated a cat's severe skin condition.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Pannexin 3 is important for bone formation and the development of bone cells.

Entospletinib effectively prevents eye and skin GVHD in mice.

Engineered bacteria can deliver antioxidants to protect skin.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.